Cell and Gene Outsourcing

  1. Alzheimer's Imaging, Simplified 8/5/2025

    Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.

  2. Custom Antibody Development And Characterization Services 8/5/2025

    Our in-house custom antibody delivery team has a proven track record of developing antibodies to challenging targets with exacting specifications.

  3. Accelerate Path To Clinic With CMC Consultation Services 8/5/2025

    In today’s competitive and capital-constrained cell and gene therapy environment, early decisions around Chemistry, Manufacturing, and Controls (CMC) can make or break a therapy's timeline, cost-efficiency, and eventual approval. Yet many emerging cell therapy companies struggle with CMC strategy until it becomes a bottleneck.

  4. Optimizing Cell Therapy Analytics Through DoE Methodologies 8/4/2025

    Design of Experiment (DoE) methods streamline the development of robust, phase-appropriate potency and functional assays, ensuring consistent, efficient, and regulatory-aligned testing that supports scalable cell therapy development.

  5. Lentiviral Vectors: The Key To Cell And Gene Therapy Success 7/30/2025

    Lentiviral vector manufacturing is complex and highly regulated, which is why a specialized CDMO is required to ensure safe, scalable, and compliant production from early development to commercialization.

  6. Blueprint To Modernizing CDMO Manufacturing Operations 7/29/2025

    Industry 4.0 is revolutionizing CDMOs and CMOs. Find out how AI, IIoT, and automation are driving smarter, faster, and more compliant manufacturing to ensure agility, precision, and innovation.

  7. Building Digital Capabilities For An Intelligent Tomorrow 7/29/2025

    Explore how modern manufacturing software is transforming operations with AI-driven insights to empower CDMOs and CMOs to boost efficiency, agility, and client satisfaction in a competitive landscape.

  8. Leveraging Technology For Rapid Clinical Material Delivery 7/29/2025

    Discover how one family's collaboration with a specialized CDMO enabled the rapid development of a life-saving gene therapy for their daughter diagnosed with an ultra-rare disease.

  9. Novartis Contract Manufacturing Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Review biologics CDMO solutions and capacity offered by Novartis Contract Manufacturing. We discuss our capabilities in mammalian cell culture manufacturing and microbial fermentation.

  10. Novartis Contract Manufacturing Capacity Update July 2025: Fill/Finish 7/28/2025

    Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.